Literature DB >> 15541581

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer Abstracted from: Andre T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.

.   

Abstract

Entities:  

Year:  2004        PMID： 15541581     DOI： 10.1016/j.ctrv.2004.09.002

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  20 in total

Review 1.  Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.

Authors:  Nathan P Staff; Guido Cavaletti; Badrul Islam; Maryam Lustberg; Dimitri Psimaras; Stefano Tamburin
Journal:  J Peripher Nerv Syst       Date:  2019-10       Impact factor: 3.494

Review 2.  The emerging role of noncoding RNAs in colorectal cancer chemoresistance.

Authors:  Ling Wei; Xingwu Wang; Liyan Lv; Yan Zheng; Nasha Zhang; Ming Yang
Journal:  Cell Oncol (Dordr)       Date:  2019-07-29       Impact factor: 6.730

Review 3.  Colorectal cancer treatment.

Authors:  Asad Qureshi; Anjali Verma; Paul Ross; David Landau
Journal:  BMJ Clin Evid       Date:  2010-04-27

4.  Risk factors for oxaliplatin-induced hypersensitivity reaction in patients with colorectal cancer.

Authors:  Qiuyan Song; Yuanxuan Cai; Kangyuan Guo; Min Li; Zaoqin Yu; Qirui Tai; Yuhang Zhao; Xuan Zhu; Chengliang Zhang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

5.  Targeting cancers in the gastrointestinal tract: role of capecitabine.

Authors:  Muhammad Wasif Saif
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

6.  Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan.

Authors:  Yoshihiro Shibata; Hiroshi Ariyama; Eishi Baba; Yasushi Takii; Taito Esaki; Kenji Mitsugi; Tanji Tsuchiya; Hitoshi Kusaba; Koichi Akashi; Shuji Nakano
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 7.  Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis.

Authors:  Giovanni Brandi; Stefania De Lorenzo; Margherita Nannini; Stefania Curti; Marta Ottone; Filippo Gustavo Dall'Olio; Maria Aurelia Barbera; Maria Abbondanza Pantaleo; Guido Biasco
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

8.  The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity.

Authors:  Laura Micheli; Lorenzo Di Cesare Mannelli; Fabio Del Bello; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Donatello Carrino; Alessandra Pacini; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

9.  Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy.

Authors:  Leonidas Apostolidis; Daniel Schwarz; Annie Xia; Markus Weiler; Andreas Heckel; Tim Godel; Sabine Heiland; Heinz-Peter Schlemmer; Dirk Jäger; Martin Bendszus; Philipp Bäumer
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

10.  Laparoscopic ovarian transposition prior to pelvic irradiation in a young female patient with advanced rectal cancer.

Authors:  Kyoichi Kihara; Seiichiro Yamamoto; Taihei Ohshiro; Shin Fujita
Journal:  Surg Case Rep       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.